Loading…
Effect of ethanol on spectral binding, inhibition, and activity of CYP3A4 with an antiretroviral drug nelfinavir
► Methanol, ethanol, isopropanol, isobutanol, and isoamyl alcohol exhibit type I spectra with CYP3A4, and ethanol shows the highest binding affinity for CYP3A4. ► Ethanol increases the spectral binding affinity of nelfinavir to CYP3A4. ► Ethanol increases the inhibition of CYP3A4 by nelfinavir. ► Et...
Saved in:
Published in: | Biochemical and biophysical research communications 2010-11, Vol.402 (1), p.163-167 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c387t-e771b3b9a6f0cb6e58910cd2e4ad51fadc3150ed32e5d44d125dce2e17d348af3 |
---|---|
cites | cdi_FETCH-LOGICAL-c387t-e771b3b9a6f0cb6e58910cd2e4ad51fadc3150ed32e5d44d125dce2e17d348af3 |
container_end_page | 167 |
container_issue | 1 |
container_start_page | 163 |
container_title | Biochemical and biophysical research communications |
container_volume | 402 |
creator | Kumar, Santosh Earla, Ravinder Jin, Mengyao Mitra, Ashim K. Kumar, Anil |
description | ► Methanol, ethanol, isopropanol, isobutanol, and isoamyl alcohol exhibit type I spectra with CYP3A4, and ethanol shows the highest binding affinity for CYP3A4. ► Ethanol increases the spectral binding affinity of nelfinavir to CYP3A4. ► Ethanol increases the inhibition of CYP3A4 by nelfinavir. ► Ethanol decreases the catalytic efficiency of nelfinavir metabolism.
Cytochrome P450 3A4 (CYP3A4) is the most abundant CYP enzyme in the liver and metabolizes approximately 50% of the drugs, including antiretrovirals. Although CYP3A4 induction by ethanol and impact of CYP3A4 on drug metabolism and toxicity is known, CYP3A4-ethanol physical interaction and its impact on drug binding, inhibition, or metabolism is not known. Therefore, we studied the effect of ethanol on binding and inhibition of CYP3A4 with a representative protease inhibitor, nelfinavir, followed by the effect of alcohol on nelfinavir metabolism. Our initial results showed that methanol, ethanol, isopropanol, isobutanol, and isoamyl alcohol bind in the active site of CYP3A4 and exhibit type I spectra. Among these alcohol compounds, ethanol showed the lowest
K
D (5.9
±
0.34
mM), suggesting its strong binding affinity with CYP3A4. Ethanol (20
mM) decreased the
K
D of nelfinavir by >5-fold (0.041
±
0.007 vs. 0.227
±
0.038
μM). Similarly, 20
mM ethanol decreased the
IC
50 of nelfinavir by >3-fold (2.6
±
0.5 vs. 8.3
±
3.1
μM). These results suggest that ethanol facilitates binding of nelfinavir with CYP3A4. Furthermore, we performed nelfinavir metabolism using LCMS. Although ethanol did not alter
k
cat, it decreased the
K
m of nelfinavir, suggesting a decrease in catalytic efficiency (
k
cat/
K
m). This is an important finding because alcoholism is prevalent in HIV-1-infected persons and alcohol is shown to decrease the response to antiretroviral therapy. |
doi_str_mv | 10.1016/j.bbrc.2010.10.014 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_911147467</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006291X10018656</els_id><sourcerecordid>911147467</sourcerecordid><originalsourceid>FETCH-LOGICAL-c387t-e771b3b9a6f0cb6e58910cd2e4ad51fadc3150ed32e5d44d125dce2e17d348af3</originalsourceid><addsrcrecordid>eNp9kEFrGzEQhUVoadykfyCHolsvWVej1e56IZdgkrQQSA4tpCehlUaxzFpyJdkh_z7aOs0xMDDw5r0H8xFyBmwODNrv6_kwRD3n7J8wZyCOyAxYzyoOTHwgM8ZYW_EeHo7J55TWjAGItv9Ejjnr6443_Yxsr6xFnWmwFPNK-TDS4GnaFi2qkQ7OG-cfz6nzKze47II_p8obqnR2e5efp-Dyz319KeiTy6tyK5NdxBzD3k0VJu4eqcfROq-Kcko-WjUm_PK6T8jv66tfyx_V7d3Nz-XlbaXrRZcr7DoY6qFXrWV6aLFZ9MC04SiUacAqo2toGJqaY2OEMMAbo5EjdKYWC2XrE_Lt0LuN4e8OU5YblzSOo_IYdkn2UGB0ou2Kkx-cOoaUIlq5jW6j4rMEJifQci0n0HICPWkFdAl9fa3fDRs0b5H_ZIvh4mDA8uTeYZRJO_QaTYGjszTBvdf_Apa8kDY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>911147467</pqid></control><display><type>article</type><title>Effect of ethanol on spectral binding, inhibition, and activity of CYP3A4 with an antiretroviral drug nelfinavir</title><source>ScienceDirect Freedom Collection</source><creator>Kumar, Santosh ; Earla, Ravinder ; Jin, Mengyao ; Mitra, Ashim K. ; Kumar, Anil</creator><creatorcontrib>Kumar, Santosh ; Earla, Ravinder ; Jin, Mengyao ; Mitra, Ashim K. ; Kumar, Anil</creatorcontrib><description>► Methanol, ethanol, isopropanol, isobutanol, and isoamyl alcohol exhibit type I spectra with CYP3A4, and ethanol shows the highest binding affinity for CYP3A4. ► Ethanol increases the spectral binding affinity of nelfinavir to CYP3A4. ► Ethanol increases the inhibition of CYP3A4 by nelfinavir. ► Ethanol decreases the catalytic efficiency of nelfinavir metabolism.
Cytochrome P450 3A4 (CYP3A4) is the most abundant CYP enzyme in the liver and metabolizes approximately 50% of the drugs, including antiretrovirals. Although CYP3A4 induction by ethanol and impact of CYP3A4 on drug metabolism and toxicity is known, CYP3A4-ethanol physical interaction and its impact on drug binding, inhibition, or metabolism is not known. Therefore, we studied the effect of ethanol on binding and inhibition of CYP3A4 with a representative protease inhibitor, nelfinavir, followed by the effect of alcohol on nelfinavir metabolism. Our initial results showed that methanol, ethanol, isopropanol, isobutanol, and isoamyl alcohol bind in the active site of CYP3A4 and exhibit type I spectra. Among these alcohol compounds, ethanol showed the lowest
K
D (5.9
±
0.34
mM), suggesting its strong binding affinity with CYP3A4. Ethanol (20
mM) decreased the
K
D of nelfinavir by >5-fold (0.041
±
0.007 vs. 0.227
±
0.038
μM). Similarly, 20
mM ethanol decreased the
IC
50 of nelfinavir by >3-fold (2.6
±
0.5 vs. 8.3
±
3.1
μM). These results suggest that ethanol facilitates binding of nelfinavir with CYP3A4. Furthermore, we performed nelfinavir metabolism using LCMS. Although ethanol did not alter
k
cat, it decreased the
K
m of nelfinavir, suggesting a decrease in catalytic efficiency (
k
cat/
K
m). This is an important finding because alcoholism is prevalent in HIV-1-infected persons and alcohol is shown to decrease the response to antiretroviral therapy.</description><identifier>ISSN: 0006-291X</identifier><identifier>EISSN: 1090-2104</identifier><identifier>DOI: 10.1016/j.bbrc.2010.10.014</identifier><identifier>PMID: 20937259</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Alcohol ; Alcoholism ; Alcoholism - complications ; Alcoholism - enzymology ; Anti-Retroviral Agents - pharmacokinetics ; Anti-Retroviral Agents - pharmacology ; Binding Sites - drug effects ; CYP3A4 ; Cytochrome P-450 CYP3A - chemistry ; Cytochrome P-450 CYP3A - metabolism ; Cytochrome P-450 CYP3A Inhibitors ; Ethanol - metabolism ; Ethanol - pharmacology ; HIV Infections - complications ; HIV Infections - drug therapy ; HIV Infections - enzymology ; Human immunodeficiency virus ; Humans ; Inactivation, Metabolic ; Inhibition ; Liver - enzymology ; Metabolism ; Nelfinavir ; Nelfinavir - pharmacokinetics ; Nelfinavir - pharmacology ; Protein Binding - drug effects ; Spectral binding</subject><ispartof>Biochemical and biophysical research communications, 2010-11, Vol.402 (1), p.163-167</ispartof><rights>2010</rights><rights>Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c387t-e771b3b9a6f0cb6e58910cd2e4ad51fadc3150ed32e5d44d125dce2e17d348af3</citedby><cites>FETCH-LOGICAL-c387t-e771b3b9a6f0cb6e58910cd2e4ad51fadc3150ed32e5d44d125dce2e17d348af3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27911,27912</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20937259$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kumar, Santosh</creatorcontrib><creatorcontrib>Earla, Ravinder</creatorcontrib><creatorcontrib>Jin, Mengyao</creatorcontrib><creatorcontrib>Mitra, Ashim K.</creatorcontrib><creatorcontrib>Kumar, Anil</creatorcontrib><title>Effect of ethanol on spectral binding, inhibition, and activity of CYP3A4 with an antiretroviral drug nelfinavir</title><title>Biochemical and biophysical research communications</title><addtitle>Biochem Biophys Res Commun</addtitle><description>► Methanol, ethanol, isopropanol, isobutanol, and isoamyl alcohol exhibit type I spectra with CYP3A4, and ethanol shows the highest binding affinity for CYP3A4. ► Ethanol increases the spectral binding affinity of nelfinavir to CYP3A4. ► Ethanol increases the inhibition of CYP3A4 by nelfinavir. ► Ethanol decreases the catalytic efficiency of nelfinavir metabolism.
Cytochrome P450 3A4 (CYP3A4) is the most abundant CYP enzyme in the liver and metabolizes approximately 50% of the drugs, including antiretrovirals. Although CYP3A4 induction by ethanol and impact of CYP3A4 on drug metabolism and toxicity is known, CYP3A4-ethanol physical interaction and its impact on drug binding, inhibition, or metabolism is not known. Therefore, we studied the effect of ethanol on binding and inhibition of CYP3A4 with a representative protease inhibitor, nelfinavir, followed by the effect of alcohol on nelfinavir metabolism. Our initial results showed that methanol, ethanol, isopropanol, isobutanol, and isoamyl alcohol bind in the active site of CYP3A4 and exhibit type I spectra. Among these alcohol compounds, ethanol showed the lowest
K
D (5.9
±
0.34
mM), suggesting its strong binding affinity with CYP3A4. Ethanol (20
mM) decreased the
K
D of nelfinavir by >5-fold (0.041
±
0.007 vs. 0.227
±
0.038
μM). Similarly, 20
mM ethanol decreased the
IC
50 of nelfinavir by >3-fold (2.6
±
0.5 vs. 8.3
±
3.1
μM). These results suggest that ethanol facilitates binding of nelfinavir with CYP3A4. Furthermore, we performed nelfinavir metabolism using LCMS. Although ethanol did not alter
k
cat, it decreased the
K
m of nelfinavir, suggesting a decrease in catalytic efficiency (
k
cat/
K
m). This is an important finding because alcoholism is prevalent in HIV-1-infected persons and alcohol is shown to decrease the response to antiretroviral therapy.</description><subject>Alcohol</subject><subject>Alcoholism</subject><subject>Alcoholism - complications</subject><subject>Alcoholism - enzymology</subject><subject>Anti-Retroviral Agents - pharmacokinetics</subject><subject>Anti-Retroviral Agents - pharmacology</subject><subject>Binding Sites - drug effects</subject><subject>CYP3A4</subject><subject>Cytochrome P-450 CYP3A - chemistry</subject><subject>Cytochrome P-450 CYP3A - metabolism</subject><subject>Cytochrome P-450 CYP3A Inhibitors</subject><subject>Ethanol - metabolism</subject><subject>Ethanol - pharmacology</subject><subject>HIV Infections - complications</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - enzymology</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Inactivation, Metabolic</subject><subject>Inhibition</subject><subject>Liver - enzymology</subject><subject>Metabolism</subject><subject>Nelfinavir</subject><subject>Nelfinavir - pharmacokinetics</subject><subject>Nelfinavir - pharmacology</subject><subject>Protein Binding - drug effects</subject><subject>Spectral binding</subject><issn>0006-291X</issn><issn>1090-2104</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNp9kEFrGzEQhUVoadykfyCHolsvWVej1e56IZdgkrQQSA4tpCehlUaxzFpyJdkh_z7aOs0xMDDw5r0H8xFyBmwODNrv6_kwRD3n7J8wZyCOyAxYzyoOTHwgM8ZYW_EeHo7J55TWjAGItv9Ejjnr6443_Yxsr6xFnWmwFPNK-TDS4GnaFi2qkQ7OG-cfz6nzKze47II_p8obqnR2e5efp-Dyz319KeiTy6tyK5NdxBzD3k0VJu4eqcfROq-Kcko-WjUm_PK6T8jv66tfyx_V7d3Nz-XlbaXrRZcr7DoY6qFXrWV6aLFZ9MC04SiUacAqo2toGJqaY2OEMMAbo5EjdKYWC2XrE_Lt0LuN4e8OU5YblzSOo_IYdkn2UGB0ou2Kkx-cOoaUIlq5jW6j4rMEJifQci0n0HICPWkFdAl9fa3fDRs0b5H_ZIvh4mDA8uTeYZRJO_QaTYGjszTBvdf_Apa8kDY</recordid><startdate>20101105</startdate><enddate>20101105</enddate><creator>Kumar, Santosh</creator><creator>Earla, Ravinder</creator><creator>Jin, Mengyao</creator><creator>Mitra, Ashim K.</creator><creator>Kumar, Anil</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>20101105</creationdate><title>Effect of ethanol on spectral binding, inhibition, and activity of CYP3A4 with an antiretroviral drug nelfinavir</title><author>Kumar, Santosh ; Earla, Ravinder ; Jin, Mengyao ; Mitra, Ashim K. ; Kumar, Anil</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c387t-e771b3b9a6f0cb6e58910cd2e4ad51fadc3150ed32e5d44d125dce2e17d348af3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Alcohol</topic><topic>Alcoholism</topic><topic>Alcoholism - complications</topic><topic>Alcoholism - enzymology</topic><topic>Anti-Retroviral Agents - pharmacokinetics</topic><topic>Anti-Retroviral Agents - pharmacology</topic><topic>Binding Sites - drug effects</topic><topic>CYP3A4</topic><topic>Cytochrome P-450 CYP3A - chemistry</topic><topic>Cytochrome P-450 CYP3A - metabolism</topic><topic>Cytochrome P-450 CYP3A Inhibitors</topic><topic>Ethanol - metabolism</topic><topic>Ethanol - pharmacology</topic><topic>HIV Infections - complications</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - enzymology</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Inactivation, Metabolic</topic><topic>Inhibition</topic><topic>Liver - enzymology</topic><topic>Metabolism</topic><topic>Nelfinavir</topic><topic>Nelfinavir - pharmacokinetics</topic><topic>Nelfinavir - pharmacology</topic><topic>Protein Binding - drug effects</topic><topic>Spectral binding</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kumar, Santosh</creatorcontrib><creatorcontrib>Earla, Ravinder</creatorcontrib><creatorcontrib>Jin, Mengyao</creatorcontrib><creatorcontrib>Mitra, Ashim K.</creatorcontrib><creatorcontrib>Kumar, Anil</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Biochemical and biophysical research communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kumar, Santosh</au><au>Earla, Ravinder</au><au>Jin, Mengyao</au><au>Mitra, Ashim K.</au><au>Kumar, Anil</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of ethanol on spectral binding, inhibition, and activity of CYP3A4 with an antiretroviral drug nelfinavir</atitle><jtitle>Biochemical and biophysical research communications</jtitle><addtitle>Biochem Biophys Res Commun</addtitle><date>2010-11-05</date><risdate>2010</risdate><volume>402</volume><issue>1</issue><spage>163</spage><epage>167</epage><pages>163-167</pages><issn>0006-291X</issn><eissn>1090-2104</eissn><abstract>► Methanol, ethanol, isopropanol, isobutanol, and isoamyl alcohol exhibit type I spectra with CYP3A4, and ethanol shows the highest binding affinity for CYP3A4. ► Ethanol increases the spectral binding affinity of nelfinavir to CYP3A4. ► Ethanol increases the inhibition of CYP3A4 by nelfinavir. ► Ethanol decreases the catalytic efficiency of nelfinavir metabolism.
Cytochrome P450 3A4 (CYP3A4) is the most abundant CYP enzyme in the liver and metabolizes approximately 50% of the drugs, including antiretrovirals. Although CYP3A4 induction by ethanol and impact of CYP3A4 on drug metabolism and toxicity is known, CYP3A4-ethanol physical interaction and its impact on drug binding, inhibition, or metabolism is not known. Therefore, we studied the effect of ethanol on binding and inhibition of CYP3A4 with a representative protease inhibitor, nelfinavir, followed by the effect of alcohol on nelfinavir metabolism. Our initial results showed that methanol, ethanol, isopropanol, isobutanol, and isoamyl alcohol bind in the active site of CYP3A4 and exhibit type I spectra. Among these alcohol compounds, ethanol showed the lowest
K
D (5.9
±
0.34
mM), suggesting its strong binding affinity with CYP3A4. Ethanol (20
mM) decreased the
K
D of nelfinavir by >5-fold (0.041
±
0.007 vs. 0.227
±
0.038
μM). Similarly, 20
mM ethanol decreased the
IC
50 of nelfinavir by >3-fold (2.6
±
0.5 vs. 8.3
±
3.1
μM). These results suggest that ethanol facilitates binding of nelfinavir with CYP3A4. Furthermore, we performed nelfinavir metabolism using LCMS. Although ethanol did not alter
k
cat, it decreased the
K
m of nelfinavir, suggesting a decrease in catalytic efficiency (
k
cat/
K
m). This is an important finding because alcoholism is prevalent in HIV-1-infected persons and alcohol is shown to decrease the response to antiretroviral therapy.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>20937259</pmid><doi>10.1016/j.bbrc.2010.10.014</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-291X |
ispartof | Biochemical and biophysical research communications, 2010-11, Vol.402 (1), p.163-167 |
issn | 0006-291X 1090-2104 |
language | eng |
recordid | cdi_proquest_miscellaneous_911147467 |
source | ScienceDirect Freedom Collection |
subjects | Alcohol Alcoholism Alcoholism - complications Alcoholism - enzymology Anti-Retroviral Agents - pharmacokinetics Anti-Retroviral Agents - pharmacology Binding Sites - drug effects CYP3A4 Cytochrome P-450 CYP3A - chemistry Cytochrome P-450 CYP3A - metabolism Cytochrome P-450 CYP3A Inhibitors Ethanol - metabolism Ethanol - pharmacology HIV Infections - complications HIV Infections - drug therapy HIV Infections - enzymology Human immunodeficiency virus Humans Inactivation, Metabolic Inhibition Liver - enzymology Metabolism Nelfinavir Nelfinavir - pharmacokinetics Nelfinavir - pharmacology Protein Binding - drug effects Spectral binding |
title | Effect of ethanol on spectral binding, inhibition, and activity of CYP3A4 with an antiretroviral drug nelfinavir |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T18%3A03%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20ethanol%20on%20spectral%20binding,%20inhibition,%20and%20activity%20of%20CYP3A4%20with%20an%20antiretroviral%20drug%20nelfinavir&rft.jtitle=Biochemical%20and%20biophysical%20research%20communications&rft.au=Kumar,%20Santosh&rft.date=2010-11-05&rft.volume=402&rft.issue=1&rft.spage=163&rft.epage=167&rft.pages=163-167&rft.issn=0006-291X&rft.eissn=1090-2104&rft_id=info:doi/10.1016/j.bbrc.2010.10.014&rft_dat=%3Cproquest_cross%3E911147467%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c387t-e771b3b9a6f0cb6e58910cd2e4ad51fadc3150ed32e5d44d125dce2e17d348af3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=911147467&rft_id=info:pmid/20937259&rfr_iscdi=true |